sorafenib teva 200 mg filmsko obložene tablete
sorafenib - filmsko obložena tableta - sorafenib 200 mg / 1 tableta - sorafenib
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologi - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
abirateron teva 500 mg filmsko obložene tablete
abirateron - filmsko obložena tableta - abirateron 446,3 mg / 1 tableta - abirateron
kabazitaksel teva 10 mg/ml koncentrat za raztopino za infundiranje
kabazitaksel - koncentrat za raztopino za infundiranje - kabazitaksel 10 mg / 1 ml - kabazitaksel